What's in InnoPharmax Inc.'s pipeline?

InnoPharmax Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with InnoPharmax Inc.'s portfolio?

Top competitors by shared drug class: ATS Clinical Research, Eurofarma Laboratorios S.A., Faculdade de Medicina do ABC, Istituto Auxologico Italiano, Novartis.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/innopharmax-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

InnoPharmax Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

InnoPharmax Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
D07001-Softgel Capsules	D07001-Softgel Capsules	phase 3	Selective serotonin reuptake inhibitor	Serotonin transporter	Psychiatry

Therapeutic area mix

Psychiatry · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ATS Clinical Research · 1 shared drug class
Eurofarma Laboratorios S.A. · 1 shared drug class
Faculdade de Medicina do ABC · 1 shared drug class
Istituto Auxologico Italiano · 1 shared drug class
Novartis · 1 shared drug class
Shanghai Mental Health Center · 1 shared drug class
Sichuan Baili Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for InnoPharmax Inc.:

Cite this brief

Drug Landscape (2026). InnoPharmax Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/innopharmax-inc. Accessed 2026-05-16.